ProBA - Agenzia sanitaria e sociale regionale - Regione Emilia ...

ProBA Progetto Bambini e antibiotici. I determinanti della prescrizione nelle infezioni delle alte vie respiratorie
• Chiu S.S., Ho P.L., Chow F.K.H., Yuen K.Y., Lau Y.L. Nasopharyngeal Carriage
of Antimicrobial-Resistant Streptococcus pneumoniae among Young Children Attending
79 Kindergartens and Day Care Centers in Hong Kong. Antimicrobial Agents and
Chemotherapy, 45: 2765-2770, 2001.
• Clavenna A., Bonati M., Rossi E., Berti A., De Rosa M. Il profilo prescrittivo della
popolazione pediatrica italiana nelle cure primarie ARNO. Ricerca e pratica, 20: 224-244,
2004.
• Collett C.A., Pappas D.E., Evans B.A., Hayden G.F. Parental knowledge about common
respiratory infections and antibiotic therapy in children. South Med J, 92: 971-976, 1999.
• Craig W.A. Does the dose matter? Clin Infect Dis, 33 (Suppl 3): S233-S237, 2001.
• Crowe C.C., Sanders W.E. Jr, Longley S. Bacterial interference. II. Role of the normal
throat flora in prevention of colonization by group A Streptococcus. J Infect Dis, 128:
527-532, 1973.
• Damoiseaux R.A., Van Balen F.A., Hoes A.W., Verheij T.J., de Melker R.A. Primary care
based randomised, double blind trial of amoxicillin versus placebo for acute otitis media
in children aged under 2 years. BMJ, 320: 350-354, 2000.
• Dancer S.J. How antibiotics can make us sick: the less obvious adverse effects
of antimicrobial chemotherapy. Lancet Infect Dis, 4: 611-619, 2004.
• Decousser J.W., Pina P., Viguier F., Picot F., Courvalin P., Allouch P. Invasive
Streptococcus pneumoniae in France: Antimicrobial Resistance, Serotype, and Molecular
Epidemiology Findings from a Monthly National Study in 2000 to 2002. Antimicrobial
Agents and Chemotherapy, 48: 3636-3639, 2004.
• Del Mar C.B., Glasziou P.P., Hayem M. Are antibiotics indicated as initial treatment
for children with acute otitis media? A meta-analysis. BMJ, 314: 1526, 1997.
• Diaz M.C., Symons N., Ramundo M.L., Christopher N.C. Effect of a Standardized
Pharyngitis Treatment Protocol on Use of Antibiotics in a Pediatric Emergency
Department. Archives of Pediatrics Adolescent Medicine, 158: 977-981, 2004.
• Diekema D.J., Brueggemann A.B., Doern G.V. Antimicrobial-drug use and changes in
resistance in Streptococcus pneumoniae. Emerg Infect Dis, 6: 552-556, 2000.
• Doern G.V. Antimicrobial use and the emergence of antimicrobial resistance with
Streptococcus pneumoniae in the United States. Clin Infect Dis, 33 (Suppl 3): S187-S192,
2001.
• Doern G.V., Heilmann K.P., Huynh H.K., Rhomberg P.R., Coffman S.L., Brueggemann
A.B. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the
United States during 1999-2000, including a comparison of resistance rates since 1994-
1995. Antimicrobial Agents and Chemotherapy, 45: 1721-1729, 2001.
• Dowell S.F., Schwartz B. Resistant pneumococci: protecting patients through judicious
use of antibiotics. Am Fam Physician, 55: 1647-1648, 1997.
• Dowell S.F., Schwartz B., Phillips W.R. Appropriate use of antibiotics for URIs in
children: Part I. Otitis media and acute sinusitis. The Pediatric URI Consensus Team.
Am Fam Physician, 58 (5): 1113-1118, 1123, 1998a.
Dossier 115
99